The c-Abl inhibitor, Radotinib HCl is neuroprotective in a preclinical Parkinson's disease mouse model.
Lee S, Kim S, Park YJoo, Yun SPil, Kwon S-H, Kim D, Kim DYeon, Shin JSoo, Cho DJin, Lee GYeal, et al. The c-Abl inhibitor, Radotinib HCl is neuroprotective in a preclinical Parkinson's disease mouse model. Hum Mol Genet. 2018.